ENaC regulation and its role in blood pressure homeostasis
ENaC regulation and its role in blood pressure homeostasis
批准号:
10338091
负责人:
Annet Kirabo
金额:
$75.35万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
未结题
起止时间:
1996-05-01 至 2025-01-31
关键词:
AbbreviationsAddressAffectAldosteroneAllelesAmilorideAngiotensin IIAnimal ModelAntigensArgipressinBindingBlood PressureBone MarrowBone Marrow TransplantationCellsClinicalDatabasesDendritic Cell PathwayDendritic CellsDietDiseaseDistalElectrolytesEssential HypertensionExcretory functionExtracellular DomainExtracellular FluidFamilyGenesGeneticGenetically Engineered MouseHealthHomeostasisHormonesHumanHypertensionHypotensionIndividualInflammationInflammatoryIntakeIon ChannelKidneyKnock-in MouseLinkLiquid substanceMendelian disorderModificationMouse StrainsMusMyeloid CellsNADPH OxidaseNephronsPalmitatesPeptide HydrolasesPost-Translational Protein ProcessingProbabilityProcessProductionProteolysisRegulationRiskRoleSignal PathwaySingle Nucleotide PolymorphismSiteSodiumSuperoxidesSystemT cell differentiationTrans-Omics for Precision MedicineVariantblood pressure controlblood pressure elevationblood pressure regulationcell typecytokinedbSNPdietarydietary saltepithelial Na+ channelexperimental studyextracellulargain of functionhigh salt dietin vivoinsightloss of functionloss of function mutationmembermutantnovelpalmitoylationresponsesalt sensitive hypertensiontargeted treatmenturinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Epithelial Na+ channels (ENaCs) are one of several key Na+ transporters in the aldosterone-sensitive distal
nephron (ASDN) that participate in the reabsorption of filtered Na+ in a highly regulated manner. These Na+
transporters have important roles in the regulation of extracellular fluid volume and blood pressure. In addition
to the ASDN, ENaCs are expressed at other sites that influence blood pressure. For example, ENaCs are
expressed in antigen presenting dendritic cells where they appear to have a role in linking a high salt diet,
inflammation and blood pressure. Proposed studies in Aim 1 will use a novel mouse ENaC gamma subunit
hypomorph to elucidate the roles of ENaC in myeloid cells (dendritic cells) and non-myeloid cells (e.g.,
principal cells of the ASDN) in the blood pressure response to a high salt diet. Rare gain- or loss-of-function
mutations within ENaC subunits have been described in Mendelian disorders characterized by hypertension or
hypotension, respectively. Gene sequencing efforts have revealed hundreds of non-synonymous single
nucleotide variants (nsNSVs) in human genes the encoding alpha, beta and gamma subunits. An increasing
number of functional nsNSVs have been identified, although the potential contributions of the vast majority of
these variants to human health and disease states are unknown. We have identified specific nsSNVs in the
large extracellular regions of ENaC subunits that either enhance or inhibit channel activity by altering a
regulatory response to extracellular Na+, referred to as Na+ self-inhibition. We have introduced specific gain-
or loss-of-function variants into mice, corresponding to known functional human ENaC nsSNVs. Studies in Aim
2 will determine whether a gain-of-function variant predisposes mice to salt-sensitive hypertension, and
whether a loss-of-function variant protects against salt-sensitive hypertension. Cleavage of ENaC subunits by
specific proteases, and modification of ENaC subunits by the addition of palmitate, activate the channel. We
have created novel mouse strains expressing ENaC subunits that lack key sites for protease cleavage or
palmitoylation. Proposed studies in Aim 3 will define the roles of these regulatory processes in the adaptation
to a low or high salt diet. The results from these studies will provide important insights regarding the role of
dendritic cell ENaC in the blood pressure response to dietary salt in mice, demonstrate that ENaC variants that
affect channel function by altering Na+ self-inhibition affect blood pressure in mice, and demonstrate the
functional roles of ENaC subunit proteolysis and palmitoylation in mice.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fcvm.2023.1205475
发表时间:
2023
期刊:
FRONTIERS IN CARDIOVASCULAR MEDICINE
影响因子:
3.6
作者:
[Masenga, Sepiso K., Kirabo, Annet]
通讯作者:
Kirabo, Annet
DOI:
10.1161/circresaha.123.322552
发表时间:
2023-03
期刊:
Circulation research
影响因子:
20.1
作者:
[S. Dikalov;Annet Kirabo]
通讯作者:
S. Dikalov;Annet Kirabo
In Memoriam: Fernando Elijovich.
悼念:费尔南多·埃利乔维奇。
DOI:
10.1161/hypertensionaha.122.20541
发表时间:
2023
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Ertuglu,LaleA, Laffer,CherylL, Kirabo,Annet]
通讯作者:
Kirabo,Annet
HIV-Host Cell Interactions.
HIV - 宿主细胞相互作用。
DOI:
10.3390/cells12101351
发表时间:
2023-05-09
期刊:
CELLS
影响因子:
6
作者:
[Masenga, Sepiso K., Mweene, Bislom C., Luwaya, Emmanuel, Muchaili, Lweendo, Chona, Makondo, Kirabo, Annet]
通讯作者:
Kirabo, Annet
Salt taste sensitivity, genetics and salt sensitivity of blood pressure in HIV
-
批准号:10748253
-
项目类别:
-
资助金额:$21.58万
-
财政年份:2023
-
负责人:Annet Kirabo
-
依托单位:
Deep phenotypic and functional characterization of salt-responsive immune cells in human salt senstive hypertension using CTE-seq
-
批准号:10337042
-
项目类别:
-
资助金额:$8.65万
-
财政年份:2021
-
负责人:Annet Kirabo
-
依托单位:
Immune Mechanisms of Salt-Sensitive hypertension
-
批准号:10401485
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Annet Kirabo
-
依托单位:
Immune Mechanisms of Salt-Sensitive hypertension
-
批准号:10210910
-
项目类别:
-
资助金额:$71.14万
-
财政年份:2021
-
负责人:Annet Kirabo
-
依托单位:
Deep phenotypic and functional characterization of salt-responsive immune cells in human salt senstive hypertension using CTE-seq
-
批准号:10095170
-
项目类别:
-
资助金额:$8.65万
-
财政年份:2021
-
负责人:Annet Kirabo
-
依托单位:
Immune Mechanisms of Salt-Sensitive hypertension
-
批准号:10613511
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Annet Kirabo
-
依托单位:
Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction
-
批准号:10418658
-
项目类别:
-
资助金额:$75.95万
-
财政年份:2021
-
负责人:Annet Kirabo
-
依托单位:
Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction
-
批准号:10625349
-
项目类别:
-
资助金额:$75.95万
-
财政年份:2021
-
负责人:Annet Kirabo
-
依托单位:
Role of Salt, Isoketal-modified Proteins and Dendritic Cells in Hypertension
-
批准号:9014703
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2016
-
负责人:Annet Kirabo
-
依托单位:
海外基金